dermatan sulfate has been researched along with Enlarged Liver in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bullaro, J; Fox, JE; Kakkis, ED; Sly, WS; Volpe, L | 1 |
Beaudet, AL; Ferrante, NM; Ferry, GD; Nichols, BL | 1 |
2 other study(ies) available for dermatan sulfate and Enlarged Liver
Article | Year |
---|---|
First human treatment with investigational rhGUS enzyme replacement therapy in an advanced stage MPS VII patient.
Topics: Administration, Intravenous; Body Weight; Child; Dermatan Sulfate; Enzyme Replacement Therapy; Glucuronidase; Glycosaminoglycans; Heparitin Sulfate; Hepatomegaly; Humans; Male; Mucopolysaccharidosis VII; Quality of Life; Splenomegaly; Therapies, Investigational | 2015 |
Beta-glucuronidase deficiency (mucopolysaccharidosis type VII).
Topics: Cells, Cultured; Dermatan Sulfate; Female; Fibroblasts; Glucuronidase; Glycosaminoglycans; Heparitin Sulfate; Hepatomegaly; Humans; Infant; Infant, Newborn; Intellectual Disability; Jaundice, Neonatal; Molecular Weight; Mucopolysaccharidoses | 1974 |